BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone
Clinical trial NCT03355014 · COMPLETED
Trial details
- NCT number
- NCT03355014
- Sponsor
- LG Chem
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2018-01-12
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.